Want to join the conversation?
Biopharma company $GILD announced the pricing of senior notes of $5Bil, consisting of 5 tranches; $500MM of 1.950% notes maturing in 2022, $750MM of 2.5% notes maturing in 2023, $1,250MM of 2.950% notes maturing in 2027, $750MM of 4% notes maturing in 2036 and $1,750MM of 4.15% notes maturing in 2047. The offering is expected to close Sept. 20.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.